Personal Products

Shares of Herbalife (NYSE: HLF) are jumping in the after-hours trade following the release of the company's Q2 earnings results. Currently, shares are higher by 8.61%, trading at $60.32; they ended the regular session lower by 0.32%, at $55.54. Herbalife reported Q2 EPS of $0.88 on revenues of $...

Morgan Stanley reiterated its Equal-weight rating on Avon Products (NYSE: AVP). On Thursday, AVP lost 3.93% of its value to end the day at $26.65. Its shares continued to slide in today's pre-market trading, falling 0.11% to stand around $26.62.

Shares of Herbalife (NYSE: HLF) are lower on the session by 1.87%, trading at $58.10. Overall call volume is now running at 2.51x the daily average, with 76% of all calls traded being purchases on the offer. 2,757 contracts have traded on the session so far. Herbalife Ltd. is a global network...

Shares of Nu Skin Enterprises (NYSE: NUS) are lower on the session by 1.01%, currently trading at $39.38. The stock has been moving largely higher over the past three months and is currently trading above the 50-day moving average. Options traders are buying puts on the name today. A short while...

Avon Products (NYSE: AVP) unveils its next round of earnings this Thursday, July 28, 2011. Here's Benzinga's advanced look at Avon Products' second quarter earnings report. Earnings and Revenue: Analysts are predicting an EPS reading of 50 cents per share and revenues of $2.89 billion. Avon...

MedcoHealth Solutions Inc (NYSE: MHS) was downgraded by BB&T Capital Markets from "buy" to "hold." MHS' shares closed at $65.96 on Friday. MHS' trailing-twelve-month profit margin is 2.16%. Roth Capital downgraded Hollysys Automation Technologies Ltd (NASDAQ: HOLI) from “buy” to “neutral.”...

Jefferies provided color on the consumer goods sector. In a research report published today, Jefferies stressed the possibility of an upside in Q2 earnings for a number of companies operating in the sector due to strong business momentum and generally conservative outlooks. In the report,...

Stocks trading at or near 52-week highs and lows provide excellent trading opportunities, as volatility tends to increase at such levels. The following stocks hit new 52-week highs in Wednesdays's trading session (listed from highest total volume to lowest): 1) Nalco Holding (NYSE: NLC): Shares...

Below are the top small-cap personal products stocks on the NYSE and the NASDAQ in terms of operating margin. The trailing-twelve-month operating margin at Revlon Inc (NYSE: REV) is 14.74%. REV's revenue for the same period is $1.35 billion. The trailing-twelve-month operating margin at Inter...

Stocks trading at or near 52-week highs and lows provide excellent trading opportunities, as volatility tends to increase at such levels. The following stocks hit new 52-week highs in Tuesday's trading session (listed from highest total volume to lowest): 1) Apple (NASDAQ: AAPL): Shares of Apple...

Many traders and investors see the 52-week high or low as an important indicator. Stocks that have a long-term trend in a certain direction are likely to continue, as that trend is the path of least resistance. In this case, shares of Estee Lauder (NYSE: EL) are hitting new 52-week highs. Traders...

Sterne Agee has issued a report adjusting the estimates for Arrow Financial Corporation (NASDAQ: AROW). According to the report, "While we remain positive on the fundamental trends at the institution with the stock trading at 13.3x our revised 2012 estimate and 196% of tangible book value (TBV),...

IGI Laboratories, Inc. (NYSE: IG) today announced that Jenniffer Collins has been appointed Chief Financial Officer of IGI Laboratories Inc. effective July 21, 2011. Charles Moore, President and CEO, commented, “We are pleased to welcome Jenniffer to the IGI team. She has a strong financial...

Transcept Pharmaceuticals Inc (NASDAQ: TSPT) shares fell 40.98% to create a new 52-week low of $5.07. TSPT reported that it expects a second rejection letter from the US Food and Drug Administration. Mannatech Incorporated (NASDAQ: MTEX) shares dropped 1.10% to create a new 52-week low of $0.90....

Oppenheimer & Co. is reiterating its Outperform rating and $36 price target on shares of Elizabeth Arden (NASDAQ: RDEN). In a note to clients, Oppenheimer & Co. writes, "While shares of RDEN have been somewhat range-bound throughout much of this year, our bull case remains very much intact...